1.	Phase II Chemotherapy with Spirogermanium for Advanced Gynecologic Tumors Phase: Phase II Type: Treatment Status: Closed Age: 70 and under Sponsor: Protocol IDs: UMCC-8036
2.	Phase II Master Protocol to Evaluate Chemotherapeutic Agents or Combinations for Refractory Malignant Glioma --- SPG Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-1382
3.	Phase II Chemotherapy with Spirogermanium for Advanced Stage III/IV Adenocarcinoma of the Breast Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-PB-181, WCCC-CO-8012
4.	Phase II Master Protocol Chemotherapy with New Single Agents in Patients with Stage II/III non-Small Cell Carcinoma of the Lung --- Spirogermanium Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: ICC-81L3, NCI-T83-0925D, T83-0925
5.	Phase II Chemotherapy with Spirogermanium in Metastatic Lung Cancer of All Histologies Phase: Phase II Type: Treatment Status: Completed Age: 15 and over Sponsor: Protocol IDs: MDA-DM-8287, NCI-C83-0419
6.	Phase II Chemotherapy with Spirogermanium for Metastatic Malignant Melanoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8240
7.	Phase II Chemotherapy with Spirogermanium for Renal Cell Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8218
8.	Phase II Chemotherapy with Spirogermanium for Metastatic Gastric, Colorectal, and Miscellaneous Gastrointestinal Malignant Neoplasms Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: Protocol IDs: MDA-DT-8173, NCI-C83-0555
9.	Phase II Master Protocol for Single-Agent Chemotherapy for Previously Treated Stage III/IV Hodgkin's and non-Hodgkin's Lymphoma --- PALA, AMSA, SPG, DCF (Summary Last Modified 06/97). Phase: Phase II Type: Treatment Status: Completed Age: 15 to 76 Sponsor: NCI Protocol IDs: EST-1480
10.	Phase II Master Protocol Chemotherapy for Metastatic or Recurrent Gastric Cancer --- VP-16 vs DHAD (Summary Last Modified 06/97). Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-5282
11.	Phase II Master Protocol Chemotherapy with New Agents for Metastatic or Recurrent Colorectal Cancer --- ATDA vs ICRF-187 vs SPG and CHIP vs CBDCA Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-4282
12.	Phase II Master Protocol for Evaluation of New Treatments in Patients with Residual, Recurrent, or Metastatic Pancreatic Adenocarcinoma --- DHAD vs ACM vs SPG vs VP-16 Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: EST-1283
13.	Phase II Sequential Chemotherapy with High-Dose ARA-C and SPG for Refractory or Relapsed Lymphoma Phase: Phase II Type: Treatment Status: Closed Age: 15 to 70 Sponsor: Protocol IDs: MDA-DM-8247, NCI-C82-1308
14.	Phase II Chemotherapy with Spirogermanium for Refractory Multiple Myeloma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DM-8259, NCI-C82-1315
15.	Phase II Chemotherapy with Spirogermanium for Previously Treated Adenocarcinoma of the Prostate Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8217
16.	Phase II Chemotherapy with SPG for Refractory Grade III/IV Central Nervous System Tumors Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: SWOG-8239
17.	Phase II Chemotherapy with Spirogermanium for Refractory Hodgkin's Disease and non-Hodgkin's Lymphoma Phase: Phase II Type: Treatment Status: Closed Age: under 70 Sponsor: Protocol IDs: UMCC-8005
18.	Phase II Evaluation of Spirogermanium as a Continuous Infusion for Recurrent or Metastatic, Refractory Ovarian Carcinoma in Adults Phase: Phase II Type: Treatment Status: Closed Age: 15 and over Sponsor: Protocol IDs: MDA-DM-8207
19.	Phase II Chemotherapy with Spirogermanium for Metastatic Breast Cancer Phase: Phase II Type: Treatment Status: Completed Age: over 15 Sponsor: Protocol IDs: MDA-DM-8220
20.	Phase II Chemotherapy with Spirogermanium for Unresectable, Recurrent, or Metastatic Colorectal Carcinoma Phase: Phase II Type: Treatment Status: Closed Age: under 76 Sponsor: NCI Protocol IDs: CLB-8075
21.	Phase II Chemotherapy with Spirogermanium for Recurrent or Refractory Adenocarcinoma of the Breast Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: CLB-8076
22.	Phase II Chemotherapy with Spirogermanium for Advanced, Inoperable Renal Cell Adenocarcinoma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: CLB-8172
23.	Phase II Master Protocol for Single-Agent Chemotherapy for Refractory Small Cell Bronchogenic Carcinoma --- Spirogermanium vs N-Methylformamide Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-4583
24.	Phase II Master Protocol for Single-Agent Chemotherapy for Advanced non-Small Cell Lung Cancer --- 4-Demethoxydaunorubicin Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: EST-3583
25.	Phase II Chemotherapy with Spirogermanium in Patients with Refractory Multiple Myeloma Phase: Phase II Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: NWBCC-H-0382, NCI-T83-1029D